Skip to main content

Tyra Biosciences, Inc.

TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001863127

In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Tyra Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of TYRA: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders7779+2
Shares46.9M46.8M−37.3K (−0.1%)
Value$768.4M$748.6M−$19.8M (−2.6%)

New holders (18)

Institutions that held Tyra Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to TYRA in Q2 2024
InstitutionSharesValue% of portfolio
Avidity Partners Management LP373,000$5.96M0.25%
Ally Bridge Group (NY) LLC264,660$4.23M2.52%
Ensign Peak Advisors, Inc190,557$3.05M0.01%
Jennison Associates LLC149,350$2.39M0.00%
Woodline Partners LP88,656$1.42M0.01%
Tang Capital Management LLC42,223$675.1K0.07%
Jane Street Group, LLC40,998$655.6K0.00%
State of Wisconsin Investment Board38,065$608.7K0.00%
Alliancebernstein L.P.17,570$280.9K0.00%
HighVista Strategies LLC16,078$257.1K0.09%
Parkwood LLC14,056$225.0K0.03%
Corebridge Financial, Inc.10,931$174.8K0.00%
Mariner, LLC10,785$172.5K0.00%
Mirae Asset Global ETFs Holdings Ltd.6,508$104.1K0.00%
Virtus ETF Advisers LLC4,560$72.9K0.04%
Advisor Group Holdings, Inc.34$5440.00%
SRS Capital Advisors, Inc.7$1120.00%
Covestor Ltd6$00.00%

Sold out (16)

Institutions that held Tyra Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.